Skip to main content

A discussion by Safir Anand on the laws and codes of practices governing advertising of medicinal products in India.

In India, pharmaceutical advertising is governed by The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and The Drugs and Cosmetics Rules, 1945. However these Acts do not lay down the minimum essential information requirements for advertisements. The Organization of Pharmaceutical Producers of India in its Code of Pharmaceutical Marketing Practices also provide guidelines for the information requirements in advertisements and the allowed practices for the promotion of pharmaceutical products. The Indian department of Pharmaceuticals has also come up with a Code of Marketing Practice for Indian Pharmaceutical Industry which is a voluntary code of Marketing Practices for Indian Pharmaceutical Industry.

This chapter was published in ICLG’s Pharmaceutical Advertising 2013.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Aug 01, 2026

On 24 May 2024, after roughly a quarter-century of negotiation, the Member States of the World Intellectual Property Organisation adopted, by consensus

WIPO GRATK Treaty: India Helped Write and Would Not Sign
News & Updates, Thought Leadership
Jul 17, 2026

First published by Lexology. Authors: Sandhya Singh and Sampada Kapoor Modern sport is no longer merely an athletic competition; it is a multi-billion-dollar

Managing Ambush Marketing: Legal and Commercial Perspectives
News & Updates, Thought Leadership
Jul 16, 2026

First published by IP Stars. Authors: Safir Anand and Sehr Anand In a digital landscape where the internet never forgets, an individual’s past can

The Right Not to Be Published: Inside the Delhi High Court’s Landmark ‘Right to Be Forgotten’ Judgment
News & Updates, Thought Leadership
Jul 14, 2026

First published by Lexology. Authors: Lakshmidevi Somanath and Kanishka Vaish I. The Quiet Trend of Strong Evidence Engineering Anyone who has appeared

Evidence Engineering in IP Litigation